4//SEC Filing
Cantrell Gary 4
Accession 0001567619-21-008229
CIK 0001385818other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 4:51 PM ET
Size
5.6 KB
Accession
0001567619-21-008229
Insider Transaction Report
Form 4
Cantrell Gary
Director
Transactions
- Award
Common Stock
2021-04-16+187,804→ 204,089 total
Footnotes (1)
- [F1]Grant of restricted shares. The restricted shares have the following accelerated vesting conditions: (1) The consummation of a Sale Event. (2) The closing price of the Company's stock price is equal or greater than forty dollars per share ($40) for two consecutive trading days. (3) The Grantee's service with the Company or a Related Entity is terminated by the Company without Cause (as defined below). The restricted shares vest as follows, and have no voting or dispositive rights until vested: 1/3 on April 16, 2022, and 1/12 on the first day of each quarter thereafter, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continuing employment with the Issuer.
Documents
Issuer
AYTU BIOPHARMA, INC
CIK 0001385818
Entity typeother
Related Parties
1- filerCIK 0001679246
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 4:51 PM ET
- Size
- 5.6 KB